` 600750 (Jiang Zhong Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600750
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -5% compared to the Shanghai Composite's 10% growth.

Stocks Performance
600750 vs Shanghai Composite

Loading
600750
Shanghai Composite
Add Stock

Performance Gap
600750 vs Shanghai Composite

Loading
600750
Shanghai Composite
Difference

Performance By Year
600750 vs Shanghai Composite

Loading
600750
Shanghai Composite
Add Stock

Competitors Performance
Jiang Zhong Pharmaceutical Co Ltd vs Peers

Shanghai Composite
600750
LLY
JNJ
NOVO B
ROG
Add Stock

Jiang Zhong Pharmaceutical Co Ltd
Glance View

Market Cap
14.5B CNY
Industry
Pharmaceuticals

Jiang Zhong Pharmaceutical Co Ltd. has etched its mark in the bustling landscape of China's pharmaceutical industry by embracing a strategic blend of traditional Chinese medicine (TCM) and modern medical practices. Founded in 1969 and headquartered in Wuhan, this company has steadily navigated the dynamic tides of China's healthcare sector. Jiang Zhong specializes in producing and marketing a wide array of TCM products, which are deeply rooted in ancient Chinese medical philosophies and practices. These offerings cater to various health needs, including gastrointestinal management, respiratory treatments, and nutritional supplements, which resonate well with China's rich cultural heritage of natural health solutions. The company's commitment to quality and efficacy has allowed it to carve out a substantial market niche where tradition meets innovation. Making money for Jiang Zhong Pharmaceutical Co Ltd. revolves around its robust distribution networks and strong brand presence across key domestic markets. The company has invested in extensive research and development initiatives to ensure its product line remains relevant and effective in addressing modern health challenges, alongside its traditional product offerings. By leveraging a diverse marketing strategy that includes partnerships with healthcare institutions, direct consumer promotions, and digital platforms, Jiang Zhong successfully taps into both local and international markets. Additionally, the company enhances its profitability through economies of scale and strategic cost management, allowing it to maintain competitive pricing while achieving substantial revenue growth. This balanced approach of blending tradition with innovation continues to fortify Jiang Zhong Pharmaceutical's position as a respected entity in both TCM and broader pharmaceutical realms.

Intrinsic Value
27.47 CNY
Undervaluation 16%
Intrinsic Value
Price
Back to Top